跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,679 条关于
“ARO-DIMER-PA”
全部
7,679
临床试验
6,314
药物
723
机构
134
资讯
508
去年
Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials
前天
FDA Approves Bexlutry, First Generic Radioligand Therapy, After Curium Wins Novartis Patent Dispute
8个月前
Arrowhead Pharmaceuticals Reports Strong Q1 2026 Results with REDEMPLO Launch Success and Promising Obesity Pipeline Data
9个月前
Arrowhead Pharmaceuticals Achieves FDA Approval for Rodemplo, Reports Strong Financial Turnaround
2年前
Arrowhead Pharmaceuticals Advances RNAi Therapies ARO-INHBE and ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals Launches First-in-Human Trial of ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
Dana-Farber Launches Innovative PA Oncology Fellowship to Address Growing Cancer Care Demands
去年
Hinge Bio Secures $30 Million to Advance GEM-DIMER Platform for Autoimmune Therapies
去年
Arrowhead's ARO-C3 Shows Promising Results in IgA Nephropathy Trial with 89% Reduction in C3 Levels
第 1 页,共 51 页
上一页
下一页